GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a prominent focus in medical investigation, largely due to its remarkable impact on treating conditions such as type 2 diabetes and obesity. New studies have shown that in addition to glucose management, GLP-1 drugs offer promise for heart health and even neurodegenerat